showing one amino acid change, from proline to threonine at position 306. All of the other members of the CMY-2 subgroup that we found in the GenBank database (www.ncbi.nlm.nih.gov) carry proline at amino acid position 306. Isoelectric focusing confirmed the production of the respective ␤-lactamases, except for SHV-12 (Table 1) .
Random amplified polymorphic DNA (RAPD) analysis with RAPD primer 5 and the Ready-To-Go RAPD analysis kit (GE Healthcare, Little Chalfont, United Kingdom) showed identical RAPD types for all three P. mirabilis isolates, suggesting clonally relatedness (Table 1) .
A PCR-based plasmid replicon typing scheme described by Carattoli et al. (7) did not yield any PCR products. Preparations obtained by using the Qiagen Plasmid Midi kit (Qiagen GmbH, Hilden, Germany) did not show any visible plasmid bands. No transformants could be obtained by transformation of those DNA preparations in E. coli DH5␣ using the MicroPulser according to the manufacturer's guidelines (Bio-Rad Laboratories, Hercules, CA).
To the best of our knowledge, this study is the first report on AmpC ␤-lactamase-and carbapenemase-producing P. mirabilis isolates in Bulgaria. The production of CMY-2 group variants by P. mirabilis isolates, which were found in four European countries, was reported by D'Andrea et al. (2) . Among them were isolates from Greece showing a combination of ␤-lactamases very similar to those of our isolates, namely, TEM-1, VIM-1, and CMY-16, which is the CMY variant closest related to CMY-99. The authors revealed a chromosomal location of the bla CMY genes of all of their isolates. The negative results of our attempts to accomplish conjugational transfer, isolation of plasmidic DNA, and transformation, as well as the absence of common plasmid replicon types, suggest that this might also be the case for our isolates. Isoelectric focusing showed no bands corresponding to the SHV-12 genes detected for P. mirabilis isolates 915 and 79. In combination with the lack of any significant inhibitory effect of clavulanic acid, this led to the assumption that the SHV-12 genes were not expressed or only very weakly expressed.
Our data document an ongoing dissemination of CMY-type ␤-lactamase-producing P. mirabilis isolates that have acquired additional resistance determinants, leading to a multiple-resistance phenotype with limited options for antibiotic treatment.
Nucleotide sequence accession number. The nucleotide sequence of bla has been deposited in the GenBank database under accession number KF305673.
